SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Centene Corp. and Reminds Investors with Losses to Contact the Firm

IRVINE, Calif.--()--Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Centene Corp. (“Centene” or the “Company”) (NYSE: CNC) concerning possible violations of federal securities laws.

If you purchased shares of Centene and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

The investigation center around on statements made after Centene’s acquisition of Health Net, Inc. on March 24, 2016. In the months after the acquisition, the Company told investors that there were no negative developments in the Health Net medical reserves. On July 26, 2016, Centene announced that it increased reserves for medical claims associated with disputed costs for substance abuse treatment centers and that it recorded “premium deficiency reserves primarily associated with Arizona and the California individual PPO business.” When this news was released to the public, Centene shares fell in value.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Khang & Khang LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

Contacts

Khang & Khang LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com